Angiogenic role of LYVE-1-positive macrophages in adipose tissue by Cho, C H et al.
University of Zurich





Angiogenic role of LYVE-1-positive macrophages in adipose
tissue
Cho, C H; Koh, Y J; Han, J; Sung, H K; Jong Lee, H; Morisada, T; Schwendener, R;
Brekken, R A; Kang, G; Oike, Y; Choi, T S; Suda, T; Yoo, O J; Koh, G Y
Cho, C H; Koh, Y J; Han, J; Sung, H K; Jong Lee, H; Morisada, T; Schwendener, R; Brekken, R A; Kang, G; Oike,
Y; Choi, T S; Suda, T; Yoo, O J; Koh, G Y (2007). Angiogenic role of LYVE-1-positive macrophages in adipose
tissue. Circulation Research, 100(4):e47-e57.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Circulation Research 2007, 100(4):e47-e57.
Cho, C H; Koh, Y J; Han, J; Sung, H K; Jong Lee, H; Morisada, T; Schwendener, R; Brekken, R A; Kang, G; Oike,
Y; Choi, T S; Suda, T; Yoo, O J; Koh, G Y (2007). Angiogenic role of LYVE-1-positive macrophages in adipose
tissue. Circulation Research, 100(4):e47-e57.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Circulation Research 2007, 100(4):e47-e57.
Angiogenic role of LYVE-1-positive macrophages in adipose
tissue
Abstract
Here we report the discovery of a characteristic dense vascular network (DVN) in the tip portion of
epididymal adipose tissue in adult mice. The DVN is formed by angiogenesis rather than by
vasculogenesis, and has functional blood circulation. This DVN and its subsequent branching may
provide a new functional route for adipogenesis. The recruitment, infiltration, and accumulation of bone
marrow-derived LYVE-1(+) macrophages in the tip region are crucial for the formation of the DVN.
Matrix metalloproteinases (MMPs) and the VEGF-VEGFR2 system are responsible not only for the
formation of the DVN, but also for the recruitment and infiltration of LYVE-1(+) macrophages into the
epididymal adipose tissue tip region. SDF-1, but not the MCP-1-CCR2 system, is a critical factor in
recruitment and ongoing retention of macrophages in this area. We also demonstrate that the tip region
of epididymal adipose tissue is highly hypoxic, and thus provides a microenvironment conducive to the
high expression and enhanced activities of VEGF, VEGFR2, MMPs, and SDF-1 in autocrine and
paracrine manners, to create an ideal niche for the recruitment, retention, and angiogenic action of
macrophages. These findings shed light on the complex interplay between macrophage infiltration,
angiogenesis, and adipogenesis in the tip region of adult epididymal adipose tissue, and provide novel
insight into the regulation of alternative outgrowth of adipose tissue.
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Angiogenic Role of LYVE-1–Positive Macrophages in
Adipose Tissue
Chung-Hyun Cho, Young Jun Koh, Jinah Han, Hoon-Ki Sung, Hyuek Jong Lee, Tohru Morisada,
Reto A. Schwendener, Rolf A. Brekken, Guson Kang, Yuichi Oike, Tae-Saeng Choi, Toshio Suda,
Ook-Joon Yoo, Gou Young Koh
Abstract—Here we report the discovery of a characteristic dense vascular network (DVN) in the tip portion of epididymal
adipose tissue in adult mice. The DVN is formed by angiogenesis rather than by vasculogenesis, and has functional
blood circulation. This DVN and its subsequent branching may provide a new functional route for adipogenesis. The
recruitment, infiltration, and accumulation of bone marrow-derived LYVE-1 macrophages in the tip region are crucial
for the formation of the DVN. Matrix metalloproteinases (MMPs) and the VEGF-VEGFR2 system are responsible not
only for the formation of the DVN, but also for the recruitment and infiltration of LYVE-1 macrophages into the
epididymal adipose tissue tip region. SDF-1, but not the MCP-1-CCR2 system, is a critical factor in recruitment and
ongoing retention of macrophages in this area. We also demonstrate that the tip region of epididymal adipose tissue is
highly hypoxic, and thus provides a microenvironment conducive to the high expression and enhanced activities of
VEGF, VEGFR2, MMPs, and SDF-1 in autocrine and paracrine manners, to create an ideal niche for the recruitment,
retention, and angiogenic action of macrophages. These findings shed light on the complex interplay between
macrophage infiltration, angiogenesis, and adipogenesis in the tip region of adult epididymal adipose tissue, and provide
novel insight into the regulation of alternative outgrowth of adipose tissue. (Circ Res. 2007;100:e47-e57.)
Key Words: adipogenesis  angiogenesis  lymphatic vessel hyaluronan receptor 1  macrophages  matrix
metalloproteinases  monocyte chemoattractant protein-1  vascular endothelial growth factor receptors
Adipose tissue is a unique organ that has reversiblegrowth depending on the balance of fat metabolism.1 It
is mainly composed of adipocytes supported by stromal-
vascular tissue, which contains vascular endothelial cells,
macrophages, and poorly characterized stem cells.2–4 Devel-
opmental growth of adipocytes through adipogenesis (defined
as development of adipoblasts into differentiated adipocytes)
is accompanied by the growth of vasculature in adipose
tissue.2,3 Recent studies using pharmacological agents or cell
implantation have proposed that the growth of adipose tissue
is angiogenesis-dependent.5–8 However, little is known about
the nature of how angiogenesis governs the growth of adipose
tissue and, inversely, how the growth of adipose tissue affects
the growth of vasculature.
Macrophages are released from the bone marrow as imma-
ture monocytes and circulate in the blood before extravasa-
tion into their target tissues, where they differentiate into
resident macrophages. Thus, macrophages are found in every
tissue of the body and, depending on the local microenviron-
ment, acquire specialized functions including phagocytosis,
antigen presentation, tissue remodeling, and the secretion of a
wide range of growth factors and cytokines.9 The distribution
and accumulation of macrophages in certain tissue are medi-
ated by several CC chemokines and growth factors.9,10
Macrophages, particularly in obese subjects, can constitute up
to 40% of the cell population within an adipose tissue
depot.11,12 The increased number of macrophages in adipose
tissue is a likely source of secreted proinflammatory factors,
which are responsible for inducing features of metabolic
syndrome.13,14 However, under normal circumstances, mac-
rophages are also widely distributed among adipocytes, and
constitute 5% to 10% of the cell population in several adipose
tissues depots. Besides their inflammatory role, it is unknown
whether macrophages may have other roles in adipose tissue.
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Here we demonstrate an angiogenic role for macrophages
in the tip region of epididymal adipose tissue (EAT), which
may be involved in the outgrowth of adipose tissue. Further-
more, we clarify the main mediators and underlying mecha-
nisms responsible for the recruitment and retention of mac-
rophages in this tissue.
Materials and Methods
Animals and Treatment
Specific pathogen-free C57BL/6J and CCR2 (/) (C57BL/6J genetic
background) mice were purchased from Jackson Laboratory (Jackson
Labs, Bar Harbor, Maine). GFP mice (C57BL/6J genetic background)
were a gift from Dr Masaru Okabe (Osaka University, Japan). Mice
were bred in our pathogen-free animal facility and 89-week-old male
mice were used for this study otherwise specifically indicated. Animal
care and experimental procedures were performed under approval from
the Animal Care Committees of KAIST and Dankook University. For
systemic depletion of macrophages, mice were treated with intraperito-
neal injections of clodrorate liposome (CDL, 12 or 40 mg/kg) as
previously described.15,16 To block endogenous VEGF, mice were
treated with intraperitoneal injection of sFlt1-Fc (5 g/d for 2 weeks,
R&D Systems) as previously described.17 As a control, dimeric-Fc
protein was applied in the same manner. To block VEGFR2, mice were
treated with intraperitoneal injections of SU11248 (60 mg/d for 8 days,
Imagene Co, Seoul, Korea) as previously described.18 As a control,
vehicle containing 0.1% DMSO was applied in the same manner. To
block matrix metalloproteinases (MMPs), mice were treated with
intraperitoneal injections of zoledronic acid (ZA, Zometa, 100 g/kg/d
for 2 weeks, Novartis Pharma Stein AG, Stein, Switzerland). As a
control, vehicle containing 0.1% DMSO was applied in the same
manner. To block SDF-1, mice were treated with intraperitoneal
injections of anti-SDF-1 blocking antibody (50 g thrice per week,
R&D systems). As a control, nonspecific anti-rat IgG antibody was
applied in the same manner.
Bone Marrow Transplantation
Bone marrow cells (2106) were harvested from the femurs and
tibias of GFP mice by flushing with ice-cold Dulbecco’s phosphate
buffered saline (DPBS, Sigma-Aldrich). The recipient mice (C57BL/
6J), 8 to 10 weeks old, were sublethally irradiated at a dose of 4.5 Gy
with a  irradiator (Gammacell 3000, MDS Nordion Inc, Canada).
Bone marrow cells were then injected intravenously into the recip-
ient mice 16 hours after irradiation. The bone marrow transplanted
mice were examined at the indicated times.
Isolation of Adipocytes and LYVE-1
Macrophages, and RT-PCR
Mice were anesthetized by intramuscular injection of a combination of
anesthetics (80 mg/kg ketamine and 12 mg/kg xylazine). The tip portion
of EATs were harvested and incubated with Hanks’s balanced salts
solution (Sigma-Aldrich) containing 0.2% type 2 collagenase (Worth-
ington) for 1 hour at 37°C. After inactivation of collagenase activity
with bovine serum, the cell suspension was filtered through a 100 m
nylon filter (BD Bioscience), and centrifuged at 400g for 5 minutes. The
floating adipocytes were separated from pelleted SVCs, and both cell
types were washed and resuspended with DPBS. LYVE-1 macro-
phages in the SVCs were enriched by using rat anti-mouse LYVE-1
monoclonal antibody19 and anti-rat IgG MicroBeads (Miltenyi Biotech)
and a Magnetic Cell Sorter (MACS, Miltenyi Biotech) according to the
manufacturer’s instructions. Enrichment of LYVE-1 macrophages was
confirmed by FACS analysis. Total RNA was extracted from the
adipocytes, enriched LYVE-1 macrophages, and LYVE-1 cell-
depleted SVCs by using Total RNA Isolation System (Promega)
according to manufacturer’s instructions. Each cDNA was made with
Reverse Transcription System (Promega), and semi-quantitative PCR
was performed with the appropriate primers (see supplementary Table I
in the online data supplement available at http://circres.ahajournals.org).
For all indicated molecules including MMP9, 30 cycles were used for
the PCR, but for MMP-7, MMP-8 and MMP-12, 35 cycles were used.
Histological and Morphometric Analysis
Mice were anesthetized by intramuscular injection of a combination
of anesthetics (80 mg/kg ketamine and 12 mg/kg xylazine), EAT
were fixed by vascular perfusion of 1% paraformaldehyde in PBS,
removed, and whole-mounted. For detection of functional blood
circulation, 400 g of fluorescein-conjugated Bauhinia Purpurea
lectin (Vector Laboratories, Inc, Burlingame, Calif) was injected
intravenously 10 minutes before perfusion-fixation. For detection of
hypoxia, Hypoxyprobe-1 (pimonidazole hydrochloride, 60 mg/kg,
Chemicon International) was injected 90 minutes before perfusion-
fixation. After blocking with 5% goat serum in PBST (0.3% Triton
X-100 in PBS) for 1 hour at room temperature, the whole-mounted
EAT were incubated overnight at 4°C with one or more of the
following primary antibodies: (a) for blood vessels, hamster anti-
PECAM-1 antibody, clone 2H8, 1:1000 (Chemicon International,
Temecula, Calif); (b) for macrophages and leukocytes, rat monoclo-
nal anti-mouse LYVE-1 antibody, 1:1,000,60 rat anti-mouse F4/80
antibody, clone Cl:A3–1, 1:1,000 (Serotec, Oxford, UK), rat anti-
mouse CD11b antibody, clone M1/70, 1:1,000 (BD Pharmingen) and
rat anti-mouse CD45, clone 30-F11, 1:1,000 (BD Pharmingen); (c)
for adipocytes, guinea pig polyclonal anti-perilipin antibody, 1:1,000
(Research Diagnostics); (d) for apoptotic cells, rabbit polyclonal
anti-caspase-3 antibody, 1:500 (Cell Signaling Technology); (e) for
hypoxic cells, FITC-conjugated mouse monoclonal anti-
Hypoxyprobe-1 antibody, clone 4.3.11.3, 1:500 (Chemicon Interna-
tional); and (f) for VEGFR-2, rabbit polyclonal anti-VEGFR-2
antibody, 1:1000 (TO14). After several washes in PBST, whole-
mounted EAT were incubated for 1 hour at room temperature with 1
or more secondary antibodies: (a) Cy3- or Cy5-conjugated anti-
hamster IgG antibody, 1:500 (Jackson ImmunoResearch Laborato-
ries); (b) FITC- or Cy5-conjugated anti-rat antibody or anti-rabbit
antibody, 1:500 (Jackson ImmunoResearch Laboratories); (c) Cy3-
conjugated anti-guinea pig antibody (Jackson ImmunoResearch Lab-
oratories). For control experiments, the primary antibody was omit-
ted or substituted with preimmune serum. Signals were visualized
and digital images were obtained using a Zeiss Apotome microscope
and a Zeiss LSM 510 confocal microscope equipped with argon and
helium-neon lasers (Carl Zeiss). For determining the extent of
macrophage infiltration, triple-stained color images with anti-
LYVE-1, anti-PECAM-1, and anti-perilipin antibodies were cap-
tured with a Zeiss LSM 510 confocal microscope. Using ImageJ
software (http://rsb.info.nih.gov/ij), the DVN area was selected as a
region-of-interest from PECAM-1/perilipin-stained images, and
LYVE-1-stained images were converted to 8-bit gray scale. Area
densities of the LYVE-1-stained images were measured from the
pixels in the region-of-interest; only pixels over a certain level (50
intensity value) were taken to exclude background fluorescence. For
determining the hypoxic region, anti-Hypoxyprobe-1 antibody-
stained images of Hypoxyprobe-1 injected and uninjected EATs
were captured from a confocal microscope. After conversion to 8-bit
gray scale by ImageJ software, the mean area densities of DVN and
body portions of EAT, and section of implanted LLC tumor were
measured from the pixels without background fluorescence. To
avoid nonspecific fluorescence of anti-Hypoxyprobe-1 antibody, the
mean area densities were subtracted from the values of
Hypoxyprobe-1-uninjected EAT.
Statistics
Values presented are means  standard deviation (SD). Significant
differences between means were determined by analysis of variance
followed by the Student-Newman-Keuls test. Statistical significance
was set at P0.05 or P0.01.
Results
Presence of a Characteristic Dense Vascular
Network in the Tip Region of EAT
To gain insight into the reciprocal interaction between the
growth of adipose tissue and the growth of vasculature, we
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chose to examine whole-mounted EAT of male mice
(C57BL/6) during postnatal development. As EAT lacks
adjacent tissues, it is relatively easy to visualize blood
vessels and adipocytes at the 3-dimensional level by
coimmunostaining with antibodies against PECAM-1 (a
component of vascular endothelial cells) and perilipin (a
membrane protein that surrounds lipid droplets).20 In
2-week-old mice, vascular endothelial cells, which have
sprouting and filopodia,21 were readily detected in most of
the vasculature of EAT, including both the tip and body
regions (Figure 1A). In 8-week-old mice, the sprouting and
filopodia were detected mainly in vascular endothelial
cells at the EAT tip region, where a characteristic dense
vascular network (DVN) was present (Figure 1A). This
observation led us to examine both the quantity and the
location of DVN in EAT during postnatal development.
The DVN was rarely detected in any region of EAT in 2
week-old mice (Figure 1B, 1C, and 1D). However, the
number of DVNs exceeding 250 m in diameter gradually
increased from 4 to 8 weeks of age, and then gradually
decreased from 10 to 12 weeks of age (Figure 1D). These
changes were similar to changes in the whole EAT mass
from 2 to 8 weeks (Figure 1D). All DVN were mainly
detected in the EAT tip region regardless of age (Figure 1B
and 1C). Interestingly, a number of small and variably-
sized protrusions of adipose tissues (“adipose bumps”)
were observed adjacent to the tip (Figure 1B). Further-
more, in an area where a DVN is located, lipid-containing
adipocytes were absent, as evidenced by a lack of
perilipin-immunostained cells (Figure 1C). From these
observations, we sought to address the question of whether
there is a relationship between the growth of adipose tissue
and the formation of the DVN in the adult EAT tip region.
Additionally, we sought the mechanism and reason behind
the formation of the DVN in this region.
Relationships Between Adipocytes, Vasculature,
Functional Circulation, and Macrophage
Distribution in the Tip Region of EAT
To define the DVN, the tip region of EAT was examined in
more detail with coimmunostaining experiments. This anal-
ysis revealed that the DVN is composed of a short segment
with a large diameter (Figure 2A), resembling a primitive
vascular plexus formed by vasculogenesis during early em-
bryogenesis. To examine distribution of lymphatic vessels in
this region, we also performed immunostaining of LYVE-1
(lymph vessel endothelial hyaluronan receptor-1),22 which is
a marker of lymphatic endothelial cells in the whole-mounted
EAT. However, there was no LYVE-1 lymphatic vessel.
Instead, this region was infiltrated by macrophages having
variable shapes and positive staining for LYVE-1 (Figure
2A), suggesting that the formation of the DVN in the tip
region could be related to the infiltration of macrophages.
Higher magnifications of these images clearly showed fre-
quent vascular sproutings in the outer margins of the DVN
and many infiltrated macrophages of varied shapes in the
DVN area (supplementary Figure IA in the online data
supplement at http://circres.ahajournals.org). In the tip re-
gion, our triple coimmunostained images revealed that ap-
proximately 90% of these LYVE-1 cells were CD11b,
which is well-known marker for macrophages, indicating that
LYVE-1 staining was an accurate marker for macrophages in
this tissue (supplementary Figure IIA). In comparison, ap-
proximately 30% to 40% or 40% to 50% of the LYVE-1
cells were F4/80 (other macrophage marker) or CD45
(common leukocyte marker), respectively (supplementary
Figure IIB and IIC). Moreover, isolated LYVE-1 macro-
phages from the SVCs of EAT displayed active phagocytic
activity (supplementary Figure III). These results suggest that
the LYVE-1 cells are different subset of macrophages. In
fact, recent report23 has described that LYVE-1 is expressed
not only in lymphatic endothelial cells, but also in a subset of
Figure 1. Presence of a characteristic
dense vascular network (DVN) in the tip
region of EAT in adult mouse. Vascula-
ture in whole-mounted EAT in mice rang-
ing from 2 to 12 weeks are visualized
with PECAM-1 immunostaining (red or
reddish brown) (A) vascular endothelial
cells having sprouting (white arrowheads)
and filopodia (green arrowheads) are
detected in most of the vasculature of
2-week-old mice, whereas, in 8 week-old
mice, these characteristics are detected
mainly in the EAT tip region. B, The
DVNs (black arrowheads) are detected
mainly in the EAT tip region of 6- and
8-week-old mice. Occasionally, a few
variably-sized protrusions of adipose tis-
sue (blue arrows) are observed near the
tip region. C, Where a characteristic DVN
is present, there are no lipid-containing
adipocytes (blue). D, Number of DVN
exceeding 250 m in diameter in the
EAT tip region and whole EAT mass (g)
at the indicated age. Bars represent
means  SD from 4 to 8 mice. *, P0.01
vs 2 weeks of age. Scale bar, 100 m.
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macrophages in the wound healing tissues and implanted
malignant tumor tissues. Other triple coimmunostained im-
ages suggested close interactions between LYVE-1 macro-
phage infiltration, formation of the DVN, and adipogenesis in
the EAT tip region (Figure 2B). Compared with the lower
portion of the tissue, the middle area of the tip region has
smaller and nonuniformly-sized lipid-containing adipocytes
with less organized blood vessels having wider diameters and
an enlarged vascular network (Figure 2B). In the top portion
of this newly-formed adipose tissue, the DVN was of char-
acteristic shape without mature lipid-containing adipocytes
(Figure 2B). Again, in this DVN, there was a massive
infiltration of macrophages, suggesting that macrophages
may play a role in the formation of a DVN in the tip portion.
Higher magnifications of these images clearly showed such
interactions between macrophage infiltration, formation of
DVN, and adipogenesis in the EAT tip region (supplementary
Figure IB). From these observations, we speculated that
longitudinal outgrowth of EAT into the upper part of the
abdominal cavity might result from the preceding macro-
phage-induced formation of the DVN and subsequent adipo-
genesis in the EAT tip region. For lipid transport from
circulation into immature preadipocytes to occur, blood
vessels would need to be functional to systemic blood
circulation. To examine whether the DVN has blood circula-
tion, fluorescein-labeled lectin was injected intravenously,
and the image of fluorescein-lectin was obtained by fluores-
cence microscopy. Approximately 75% to 85% of the DVN
was fluorescein-lectin-positive (Figure 2C and supplementary
Figure IV in the online data supplement at http://circres.
ahajournals.org), indicating that the DVN in the EAT tip
region has blood circulation. Furthermore, red blood cells
were often observed in the DVN of the nonperfused adipose
tissue (data not shown). Thus, the DVN in the EAT tip region
has blood circulation and is able to transport lipids from the
blood into immature preadipocytes in order for them to
become lipid-accumulating mature adipocytes.
Role of LYVE-1 Macrophages in the Formation
of DVN
We then analyzed the regional interaction between the DVN
and LYVE-1 macrophages. Notably, the location of accu-
mulated LYVE-1 macrophages was always proximal to and
around the DVN (Figure 2D and 2E), implying that LYVE-1
macrophages may affect the formation of the DVN. To
examine the role of macrophages in the formation of the
DVN, macrophages were depleted by single intraperitoneal
treatment of clodrorate liposome (CDL, 12 or 40 mg/kg) as
previously described15,16 in the 89-week-old mice. This
treatment efficiently depletes macrophages in a dose-
dependent manner by inducing selective apoptosis of macro-
phages in all organs, including EAT, for 1 to 2 weeks (Figure
3A). In this situation, the number of the DVN exceeding
250 m in diameter was dramatically reduced in a dose-
dependent manner (Figure 3B). Moreover, vascular sprouting
and filopodia were rarely detected in the outer margins of the
DVN. However, 3 weeks after this treatment, massive infil-
tration of macrophages and the characteristic shape of the
DVN were similarly observed in the EAT tip region (data not
shown), suggesting that circulating macrophages may dynam-
ically replenish this region with fresh macrophages, which
then participate to form the DVN.
Origin of Macrophages and Angiogenic Role in the
Formation of DVN
To clarify the origin of the macrophages in the EAT tip
region, 8-week-old mice transplanted with GFP bone mar-
row cells were examined. At 12 weeks after bone marrow
transplantation (BMT) with GFP cells, approximately 90%
to 95% of macrophages in the tip region were GFP (Figure
Figure 2. Relationships between adipocytes,
vasculature, functional circulation, and mac-
rophage distribution in the tip region of EAT.
Whole-mounted EAT from 8-week-old mice
are visualized by immunostaining of perilipin
(for adipocytes, blue), PECAM-1 (for vascula-
ture, red) and LYVE-1 (for macrophages,
green), and merged. A, A characteristic DVN
consisting of a short segment and large
diameter is present in the tip region, where
very few lipid-containing adipocytes and
large numbers of macrophages are present.
B, Between arrows and arrowheads, blood
vessels having large diameters and a large
vascular network, lipid-containing adipo-
cytes, and occasional macrophages are
present, whereas between arrowheads and
bars, a characteristic DVN, very few lipid-
containing adipocytes, and large numbers of
macrophages are present. C, Fluorescein-
labeled lectin was injected intravenously into
mice, and the image of fluorescein-lectin
(green) in the DVN (red) was obtained.
Approximately 75% to 85% (n4) of the
DVN is fluorescein-lectin, indicating that
most DVNs have blood circulation. D,
Large numbers of macrophages are local-
ized in the upper portion of and around a
characteristic DVN. Scale bar, 100 m.
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3C), indicating that most of the macrophages were derived
from bone marrow through circulation. To evaluate whether
bone marrow-derived cells act as endothelial progenitor cells
(EPCs) to form, endothelial cells in the DVN, the colocaliza-
tion of PECAM-1 immunostaining and GFP was carefully
examined. However, based on our vigorous observations, we
found no GFP cells in the endothelial cells of any charac-
teristic DVNs (Figure 3D), clearly indicating that the forma-
tion of the DVN is induced by angiogenesis through active
sprouting, not by vasculogenesis.24,25
Role of MMPs in Macrophage Infiltration and
Formation of DVN in the Tip Region of EAT
There is ample evidence that macrophage-derived growth
factors and cytokines play a major role in angiogenesis in
certain microenvironments.9,10,26 Therefore, we compared the
expression patterns of several angiogenic growth factors and
cytokines in enriched LYVE-1 macrophages, adipocytes,
and LYVE-1 macrophage-depleted stromal-vascular cells
(SVCs) (Figure 3E) of the EAT tip region by semi-
quantitative RT-PCR. Selective expression of adiponectin in
the enriched adipocytes and PECAM-1 in the LYVE-1
macrophage-depleted SVCs reflected the high efficiency of
cell separation and enrichment for each cell type from the
EAT (Figure 3E). Interestingly, the enriched LYVE-1 mac-
rophages more abundantly expressed MMP-9, MMP-12,
MMP-7, chemokine receptor-4 (CXCR4) and TNF-,
whereas the adipocytes more abundantly expressed VEGF-A,
VEGF-D, angiopoietin-1 (Ang1) and MMP-8, and the
LYVE-1 macrophage-depleted SVCs more abundantly ex-
pressed VEGF-C and MMP-2 (Figure 3F and supplementary
Figure V). Angiopoietin-2 (Ang2) was expressed in all 3 cell
types, while macrophage chemoattractant protein-1 (MCP-1)
was expressed in the enriched LYVE-1 macrophages and
LYVE-1 macrophage-depleted SVCs, and stromal cell-
derived factor-1 (SDF-1) was in the adipocytes and in the
enriched LYVE-1 macrophage-depleted SVCs (Figure 3F
and supplementary Figure V). Thus, the RT-PCR analysis
strongly suggested that MMPs secreted from the macro-
phages, adipocytes, and SVCs could play a certain role in the
formation of the DVN in the adult EAT tip region. All
members of the MMP family contain Zn2 at the catalytic
site.27 ZA is a nitrogen-containing (amino-) bisphosphonate
that inhibits proteolytic activities of MMPs possibly through
Zn2 chelation.28,29 ZA has been used for reducing complica-
tions of bone metastasis in patients with multiple myeloma
and several solid tumors with minimal side effects,30,31 and
for targeting MMP-9-expressing macrophages and reducing
angiogenesis in experimental mice.32 Therefore, to test the
role of MMPs in the formation of the DVN, we inhibited
MMP activity in mice by treatment with ZA (100 g/kg/d for
2 weeks).32 The treatment with ZA exerted significant reduc-
tions not only in the formation of the DVN and vascular
sprouting and filopodia in the outer margins of the DVN, but
also in macrophage infiltration in the tip region (Figure 4A
and 4B). These results indicate that the action of MMPs is
critically involved in macrophage infiltration and subsequent
formation of vascular sprouting, filopodia, and DVN in the
EAT tip region. To further clarify the role of MMPs in
macrophage infiltration from circulating macrophages into
the tip region, mice were treated with intraperitoneal injec-
tions of ZA (100 g/kg/d for 2 weeks) 1 week after
macrophage depletion by CDL (40 mg/kg). Two weeks after
the treatment with ZA, the treated mice showed not only
markedly-reduced macrophage accumulation in the tip re-
Figure 3. Angiogenic role and origin of mac-
rophages in the formation of DVN. A and B,
89-week-old mice were intraperitoneally
treated with 40 mg/kg (A) or the indicated
dose (B) of CDL. One week after treatment,
LYVE-1 macrophages are selectively
depleted by apoptosis (caspase3, green), but
no apoptosis is observed in the vasculature
(red) in EAT. Scale bar, 100 m. Number of
DVN exceeding 250 m in diameter in the
EAT tip region. Bars represent means  SD
from 4 mice. *, P0.01 versus control
treated EAT. C and D, BMT with bone mar-
row cells (green) derived from GFP mice was
performed to 8-week-old mice. Three
months later, LYVE-1-positive macrophages
(blue) and vasculature (red) of EAT were im-
munostained. More than 85% of LYVE-1
macrophages are bone marrow-derived
cells. Tomographic analysis shows that no
PECAM-1 cells are GFP cells. Scale bar,
100 m. E, FACS analytical profiles of
whole SVCs (blue), LYVE-1 enriched
(green) and depleted (red) cells after label-
ing with FITC-labeled anti-LYVE-1 anti-
body. x-axis represents fraction of
LYVE-1 cells as M1 (LYVE-1- cells) and
M2 (LYVE-1 cells). F, RT-PCR profiles of
various angiogenic factors in LYVE-1-
enriched SVC (a), adipocytes (b) and
LYVE-1-depleted SVC (c) in the dotted
line, VEGF-A120.
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gion, but also a severely-reduced number of DVN (Figure 4A
and 4B), indicating that the MMPs secreted by the macro-
phages, adipocytes, and SVCs play a critical role in macro-
phage infiltration into the EAT tip region.
Role of VEGF-VEGFR System in Macrophage
Infiltration and Formation of DVN in the Tip
Region of EAT
Because angiogenesis is critically dependent on VEGF ac-
tion,33,34 and all 3 cell types in EAT express the 2 main forms
of VEGF (VEGF164 and VEGF120), we examined the role of
VEGF in the formation of the DVN in the EAT tip region by
blocking VEGF by intraperitoneal treatment with sFlt1-Fc (5
g/d for 2 weeks).17 As a control, dimeric-Fc protein was
given in the same manner. Two weeks after treatment, mice
treated with sFlt1-Fc showed not only a reduced number and
size of DVN and attenuated angiogenic sprouting and filop-
odia in the DVN, but also a moderately reduced number of
macrophages in the tip region (Figure 4A and 4B), whereas
mice treated with the control dimeric-Fc protein showed no
difference from untreated mice. Moreover, variably-shaped
protruding bumps, having a small amount of macrophages
without lipid-containing adipocytes, were observed in the tip
region (Figure 4A and 4B). These data indicate that the action
of VEGF in the tip region is important in the formation of the
DVN, and that VEGF itself might act on macrophage recruit-
ment and infiltration, possibly through the VEGF-VEGFR1
system.35,36 To test whether VEGF affects the recruitment and
infiltration of bone marrow-derived macrophages into the tip
region, the mice were treated intraperitoneally with sFlt1-Fc
(5 g/d for 2 weeks) 1 week after macrophages depletion by
CDL. Two weeks after treatment with sFlt1-Fc, the treated
mice showed not only a markedly-reduced number of mac-
rophages in the tip region, but also severely inhibited sprout-
ing and filopodia in the outer margins of the DVN (Figure
4A), indicating that VEGF itself in the tip region could act on
macrophage recruitment and infiltration. The role of
VEGFR2 is critical in angiogenesis and angiogenic vascula-
ture expresses VEGFR2 abundantly.24,25,33,34 Therefore, lev-
els of VEGFR2 in the vasculature of EAT were examined.
Indeed, VEGFR2 was more highly expressed in the vascula-
tures of the DVN than in the mature vasculature in the body
region of EAT (supplementary Figure VI). To examine role
of VEGFR2 in the formation of the DVN, VEGFR2 was
blocked by intraperitoneal treatment with SU11248 (60 mg/d
for 8 days) as previously described.18 This treatment mark-
edly inhibited the formation of the DVN and, to a lesser
extent, macrophage infiltration, but the effects were less than
those in response to VEGF neutralization with sFlt1-Fc
(Figure 4B). In addition, lipid-containing adipocytes were not
detected in the protruding bump. These results indicate that
VEGFR2 plays a key role in the formation of the DVN, and
that VEGFR2-dependent formation of the DVN could facil-
itate subsequent adipogenesis in the adult EAT tip region.
The Tip Region of EAT Is Highly Hypoxic
Hypoxia is well known to induce angiogenesis, linking
vascular oxygen supply to metabolic demand.37 Massive
infiltrations of macrophages have been found in hypoxic
areas, including avascular areas of tumors.9,10,26 Furthermore,
considering that the expression of VEGF and VEGFR2 are
mainly dependent on hypoxia and that the actions of the
MMPs, VEGF, and VEGFR2 are enhanced in hypoxia, we
have reasoned to determine the extent of hypoxia in EAT
using immuno-detection of Hypoxyprobe-1. Consistent with
previous predictions,38,39 mature adipocytes in the body
region of the adipose tissue were highly hypoxic (Figure 5A
and 5K), showing a strong Hypoxyprobe-1 signal in the
cytoplasm compared with other cells and tissues of other
organs, including the lung (Figure 5C and 5K). Noticeably,
the tip region of EAT was more hypoxic compared with the
body region (Figure 5D-5K). This difference could be be-
cause of insufficient blood supply through the immature
blood vessels to this locale. In fact, the extent of hypoxia in
the tip region of EAT was higher than that of hypoxic areas
in solid cancer tissues (Figure 5J and 5K). Thus, the extreme
hypoxia in this locale may contribute to high expression
Figure 4. Role of MMPs, VEGF, VEGFR2 and
SDF-1 in macrophage infiltration and formation of
DVN in the tip region of EAT. 89-week-old mice
were treated with ZA, sFlt1-Fc (sFlt1), SU11248,
anti-SDF-1 blocking antibody (SDF1Ab), or vehicle
(control) with or without pretreatment with CDL (40
mg/kg, 3 weeks earlier). A, Two weeks later, mac-
rophages and DVN in the EAT tip region are visual-
ized by immunostaining of LYVE-1 (green) and
PECAM-1 (red). Scale bar, 100 m. B, Numbers of
macrophages are quantified by area densities of
green signal in the avascular areas of the tip
region, and the numbers of DVN exceeding
250 m in diameter in the tip region are counted.
Bars represent means  SD from 4 to 6 mice. *,
P0.01 vs control.
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levels of VEGF and VEGFR2 and may enhance the actions of
VEGF/VEGFR2/MMPs in the formation of the DVN.
Role of SDF-1 in Macrophage Infiltration and
Formation of DVN in the Tip Region of EAT
Our RT-PCR analysis (Figure 3F) also suggested that it might
have a reciprocal interaction for the recruitment and retention
of macrophages between CXCR4-expressing macrophages
and SDF-1-expressing SVCs. To examine whether SDF-1 is
necessary for the ongoing retention of macrophages in the
EAT tip region, the function of SDF-1 was blocked by
intraperitoneal treatment with an anti-SDF-1 blocking anti-
body (50 g/thrice per week). As a control, nonspecific
anti-rat IgG antibody was as administered in the same
manner. Two weeks after treatment, the mice treated with
anti-SDF-1 showed moderately reduced numbers of macro-
phages and a small number of immature DVN (Figure 4A and
4B), whereas the mice treated with control antibody showed
no difference compared with untreated mice. To examine
whether SDF-1 is necessary for macrophage mobilization and
recruitment to occur in the EAT tip region, mice were treated
with an intraperitoneal injections of anti-SDF-1 blocking
antibody, as described above, one week after macrophages
depletion by CDL. Two weeks after treatment with the
anti-SDF-1 blocking antibody, the treated mice showed
markedly reduced numbers of macrophages and showed no
DVN in the tip region (Figure 4A and 4B). These data
indicate that the action of SDF-1 is critically involved not
only in macrophage retention, but also in macrophage mobi-
lization and infiltration, and subsequent DVN formation in
the EAT tip region.
Role of MCP-1/CCR2 System in Macrophage
Infiltration and Formation of DVN in the Tip
Region of EAT
These data raise the question of how macrophages are
infiltrated into the EAT tip region. We hypothesized that
MCP-1 (also known as C-C motif chemokine ligand 2,
CCL2) might be involved in macrophage infiltration. MCP-1
is known to be a major chemokine for macrophage infiltration
in adipose tissue, particularly during obesity,40,41 and its
receptor, CCR2,42 plays a role in macrophage infiltration in
adipose tissue.43 Our immunostaining showed that a rela-
tively abundant amount of MCP-1 was detectable not only in
the vascular area but also in the avascular area of the EAT tip
region (Figure 6A). To examine the role of MCP-1/CCR2 in
macrophage infiltration in the EAT tip region, we compared
the pattern of macrophage accumulation between CCR2
(/) mice and wild-type (WT) littermates. Our data indi-
cated no difference in the pattern of macrophage accumula-
tion or in characteristics of the DVN between CCR2 (/)
mice and WT littermates (Figure 6B and 6C). To clarify the
role of the MCP-1/CCR2 system in the recruitment, infiltra-
tion, and ongoing retention of macrophages in EAT, macro-
phages in both CCR2 (/) mice and WT littermates were
depleted by CDL, and the pattern of macrophage accumula-
tion was examined. One week after the treatment, all macro-
phages had completely disappeared from the adipose tissue of
both CCR2 (/) mice and WT littermates (Figure 6B).
Three weeks after the treatment, the accumulation of macro-
phages and development of DVN in the EAT tip region of
CCR2 (/) mice were indistinguishable from those of WT
littermates (Figure 6B and 6C), whereas fewer infiltrated
macrophages were observed in the body region of EAT in
CCR2 (/) mice compared with WT littermates (Figure 6B).
The latter finding is consistent with a previous report.43 These
data suggest that the MCP-1/CCR2 system is not a critical factor
in macrophage infiltration into the EAT tip region.
Discussion
Little is known about how angiogenesis governs the growth
of adipose tissue. Here we show the angiogenic role of
macrophages that accumulate largely in the tip region of adult
EAT, which is extremely hypoxic (Figure 7). These macro-
phages are LYVE-1, originate from the bone marrow, and
induce active angiogenesis through the secretion of MMP-9,
MMP-12, and MMP-7, and activation of the VEGF-VEGFR2
system. This macrophage-induced angiogenesis is essential
for subsequent adipogenesis, which may prove to be impor-
tant for longitudinal outgrowth of adipose tissue. SDF-1 and
Figure 5. Hypoxia in EAT. 89-week-old mice
were intravenously treated with Hyproxyprobe-1
(60 mg/kg). Sixty minutes later each organ was
harvested, and Hydroxyprobe-1 (green) and blood
vessels (red) were immunostained. A, Nonlipid por-
tions of cytoplasm (white arrowheads) in adipo-
cytes contain a moderate amount of
Hydroxyprobe-1, (C) whereas almost no
Hydroxyprobe-1 is detected in lung tissue. B, Im-
munostaining of adipocytes without
Hydroxyprobe-1 injection as a negative control.
D–I, Tip (white arrowheads) and body (white
arrows) regions of EAT. J, Implanted Lewis lung
carcinoma in mice. White arrows, hypoxic area
(HA); white arrowheads, nonhypoxic area (NHA). K,
Amounts of Hydroxyprobe-1 in each tissue, each
portion of EAT, or each tumor area are quantified
by area densities of green signal in the given area
(0.05 mm2, tip region of EAT; 0.3 mm2, body region
of EAT; 0.18 mm2, tumor section). Bars represent
means  SD from 4 mice.
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VEGF, but not the MCP-1/CCR2 system, are critical factors
for the mobilization, recruitment and retention of macro-
phages to this region (Figure 7). Thus, we have elucidated the
angiogenic role of LYVE-1 macrophages that accumulate
largely in the EAT tip region and show that they could be
involved in regulating the outgrowth of adipose tissue.
Furthermore, we unveil the main mediators and underlying
mechanisms responsible for the recruitment and retention of
macrophages in this tissue (Figure 7).
We had initially been interested in examining the distribu-
tion of lymphatic vessels in EAT by immunostaining of
LYVE-1, which is a marker of lymphatic endothelial cells.22
By chance, we discovered from the coimmunostaining results
that most LYVE-1 cells in EAT were macrophages rather
than lymphatic endothelial cells. Indeed, our results reveal
that the LYVE-1 cells are variably-shaped single cells rather
than continuous tube-like lymphatic endothelial cells. More-
over, many of the LYVE-1 cells expressed well-known
markers for macrophages: 90% were CD11b, and 30% to
40% were F4/80. Importantly, LYVE-1 cells undergo
apoptosis in all organs including EAT by active phagocytosis
during 1 to 2 weeks of treatment with clodrorate lipo-
Figure 6. Role of MCP-1/CCR2 system
in macrophage infiltration and formation
of DVN in the tip region of EAT. A,
MCP-1 was immunostained (green). B,
Macrophages and DVN are visualized by
immunostaining of LYVE-1 (blue) and
PECAM-1 (red) in the 89-week-old wild
type (Wt) and CCR2 (/) mice during
the control period (0 w), and 1 and 3
weeks after CDL (40 mg/kg) treatment.
Scale bar, 100 m. C, The density of
macrophages per given density of blood
vessels in DVN (Mac/BV in DVN) is
expressed as a ratio of the amount of
blue signal to the amount of red signal in
the EAT tip regionin the control period (0
w) and 3 weeks after CDL (40 mg/kg)
treatment in WT and CCR2 (/) mice.
Bars represent means  SD from 4 to 6
mice. NS, not significant vs WT.
Figure 7. Model for complex interplay between macrophage infiltration, angiogenesis, and adipogenesis in the tip region of adult EAT.
Highly hypoxic unknown cells in the EAT tip region could provide an active microenvironment for the recruitment and retention of mac-
rophages and for the angiogenic effects of macrophages through high-level expression and enhanced activities of MCP-1, VEGF, and
SDF-1 in autocrine and paracrine manners. Once bone marrow-derived circulatory macrophages accumulate in this area, the macro-
phages secrete MMP-9, MMP-12, MMP-7, and other angiogenic factors and cytokines. On this stimulation, quiescent blood vessels
become activated, as evidenced by sprouting and VEGFR2 expression. The activated blood vessels undergo angiogenesis to form DVN
that has a blood circulation. In turn, triglyceride in blood mobilizes into adipoblasts and preadipocytes, which become lipid-containing
mature adipocytes (adipogenesis). This model is supported by the effects of several specific inhibitors at each step. ZA, MMP inhibitor;
sFlt1-Fc, VEGF inhibitor; Anti-SDF-1 antibody, SDF-1 inhibitor; CDL, selective macrophages apoptotic agent; SU11248, VEGFR2
inhibitor.
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some.15,16 Moreover, isolated LYVE-1 cells from the EAT
display active phagocytic activity. These ample pieces of
evidence indicate that the LYVE-1 cells are different subset
of macrophages. In fact, LYVE-1 is structurally related to
CD44 and other hyaluronan-binding proteins, and is selec-
tively expressed in lymphatic endothelial cells, a subset of
infiltrating macrophages found in tumors and inflamed tis-
sues, and in sinusoidal endothelium in liver and spleen.23,44
Of these LYVE-1 cells, only lymphatic endothelial cells
have the homoeobox domain related transcriptional factor
PROX-1,45 distinguishing LYVE-1 macrophages from lym-
phatic endothelial cells. The mechanisms of LYVE-1 expres-
sion and the functional significance of LYVE-1 beyond
hyaluronan transport have not been defined in detail. How-
ever, recent reports46,47 showed that LYVE-1 knockout mice
displayed an apparently normal phenotype, with no visible
alterations in hyaluronan metabolism, lymphatic vessel de-
velopment and maintenance, dendritic cell trafficking, or
tumor growth. In comparison, it is known that the expression
and function of LYVE-1 in macrophages is upregulated in
hypoxic and inflammatory conditions, and by a variety of
growth factors and cytokines.44 These conditions were ob-
served in the microenvironment of the EAT tip region. In
turn, LYVE-1 macrophages, as activated macrophages,
could to produce a vast number of factors that promote
angiogenesis; as their bone marrow-derived monocytic pre-
cursors, they secrete factors that mediate their own migration
and infiltration intohypoxic areas.9,10,26 Thus, the large num-
ber of infiltrated LYVE-1 macrophages could actively
participate in the formation of DVN in the hypoxic EAT tip
region (Figure 7).
MMP-induced degradation of matrix protein plays a criti-
cal role in tissue remodeling, including angiogenesis.48
Among MMPs, MMP-9 is of particular interest, because it is
thought to be a tumor angiogenic and metastatic factor that
signals through the VEGF-VEGFR system.49,50 MMP-9 is
also known to play a crucial role not only in macrophage
infiltration, but also in macrophage-induced angiogenesis.27
Moreover, evidence indicates that MMP-9 produced by bone
marrow-derived cells, including macrophages, contributes to
carcinogenesis.51 Furthermore, macrophages are known to
express and secrete not only MMP-9, but also MMP-12 and
MMP-7,52 and the latter MMPs are also involved in angio-
genesis.53,54 Our expression profiles of MMPs in three cell
types of the EAT tip region suggest that MMP-9, MMP-12,
and MMP-7 from LYVE-1 macrophages, MMP-8 from
adipocytes, and MMP-2 from SVCs could contribute to form
the DVN. Therefore, we sought to determine whether the
MMPs are essential for macrophage recruitment and infiltra-
tion into the locale and for formation of the DVN. Our data
obtained from using MMP inhibitor ZA indicate that the
MMPs play a critical role in macrophage infiltration and
macrophage-induced angiogenesis for the formation of DVN
in theEAT tip region (Figure 7).
VEGF is one of the adipokines that are secreted from
adipose tissues39,55; such factors could be beneficial in regen-
erative cell therapy using adipose stromal cells to treat
ischemic diseases in a paracrine manner.56 Our study reveals
that VEGF plays critical roles not only in DVN formation, but
also in macrophage recruitment and infiltration to the EAT tip
region in a paracrine manner. Moreover, VEGF, in concert
with Ang1, may act to help maintain of vascular integrity in
adipose tissue in a paracrine manner. Thus, VEGF in adipose
tissues could have multiple functions as one of the adipo-
kines. Our data also indicate that the action of SDF-1 is
critically involved not only in the ongoing retention of
macrophages, but also in macrophage mobilization and infil-
tration into the EAT tip region. The importance of chemokine
SDF-1 in the recruitment and retention of bone marrow-
derived CXCR4 (SDF-1 receptor)-positive circulating pro-
genitor cells into hypoxic ischemic and regenerative tissues
for subsequent angiogenesis has been well established.57–61
Likewise, in our study, hypoxia in the EAT tip region could
induce expression of SDF-1 and thus spur its role in macro-
phage retention; bone-marrow-derived macrophage recruit-
ment, mobilization, and infiltration; and subsequent angio-
genesis. CXCR4 is the sole SDF-1 receptor and is moderately
expressed in some subsets of leukocytes including mono-
cytes/macrophages62; its expression in macrophages is en-
hanced by hypoxia.63 Likewise, LYVE-1 macrophages in
the EAT tip region express CXCR4, and its expression can be
enhanced by hypoxia in EAT. Thus, the recruitment and
ongoing-retention of macrophages is the result of a reciprocal
interrelationship between CXCR4-expressing LYVE-1 mac-
rophages and SDF-1-expressing vascular-stromal cells, and
this relationship is eventually involved in macrophage-
induced angiogenesis and the subsequent angiogenesis-
dependent outgrowth of the EAT tip region (Figure 7).
Previous studies indicate that the growth of adipose tissue
is angiogenesis-dependent.5–8 However, these observations
are obtained from situations of active growth of adipose
tissues, such as in obese mice or implantation of preadipo-
cytes. In this study, we have focused on studying the role of
locally accumulated LYVE-1 macrophages and locally ac-
tive angiogenesis in adipogenesis only at the EAT tip region.
It is envisaged that macrophages and blood vessels in the rest
of EAT of normal are relatively quiescent and that the process
of adipogenesis in this tissue is relatively slow. Our systemic
treatments that targeted MMPs, the VEGF-VEGFR2 system,
and SDF-1 could mainly have their effects on the tip region
of adipose tissues, but not on the main portion of the adipose
tissues. This may explain why we did not observe a marked
reduction in total EAT fat mass and body weight during the
2 weeks exposure to several different treatments. However, in
the future, the role of tip growth in EAT on total growth of
EAT remains to be elucidated with long-term treatments with
several specific agents that affect the formation of DVN or
angiogenesis.
In conclusion, our findings shed light on the close interac-
tions between macrophage infiltration, angiogenesis, and
adipogenesis in the tip region of adult EAT.
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